Scarica l'app Stockscreener
706.16
1.14%
-7.8849
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$714.04
Aprire:
$710.21
Volume 24 ore:
55,350
Relative Volume:
0.10
Capitalizzazione di mercato:
$56.34B
Reddito:
$4.17B
Utile/perdita netta:
$1.03B
Rapporto P/E:
55.98
EPS:
12.6148
Flusso di cassa netto:
$940.22M
1 W Prestazione:
-1.21%
1M Prestazione:
+0.24%
6M Prestazione:
+32.83%
1 anno Prestazione:
+68.61%
Intervallo 1D:
$701.49
$710.30
Intervallo di 1 settimana:
$694.52
$726.41
Portata 52W:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
705.60 | 57.02B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
614.18 | 228.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
237.07 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
147.31 | 41.48B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.87 | 41.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Michael Erickson to succeed Jay Mazelsky as IDEXX CEO in May 2026 - Investing.com Nigeria
How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment Story - Yahoo Finance
IDEXX Laboratories Names Michael Erickson CEO - citybiz
IDEXX Labs stock steady as Stifel notes CEO transition plan - Investing.com
IDEXX Laboratories (IDXX) Announces CEO Transition - GuruFocus
IDEXX Laboratories, Inc. Announces Management Changes, Effective May 12, 2026 - marketscreener.com
IDEXX Laboratories (IDXX): From a Detractor to a Revivor - Finviz
IDEXX Laboratories (IDXX) Announces Leadership Transition - GuruFocus
IDEXX CEO to retire; insider named as successor - Mainebiz
IDEXX appoints insider Michael Erickson as new CEO - marketscreener.com
Idexx Laboratories announces planned CEO succession and transition - TipRanks
IDEXX Laboratories Announces CEO Transition - TradingView — Track All Markets
New leader to guide pet health innovator IDEXX as Michael Erickson becomes CEO - Stock Titan
Is It Too Late To Consider Buying IDEXX Laboratories (IDXX) After A 71% One Year Rally - Yahoo Finance
Will IDEXX Laboratories Inc. stock outperform value stocksCushioning Options Review & walk-ready comfort choices - ulpravda.ru
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results - 01net
Fund Update: 152,368 IDEXX LABS (IDXX) shares added to CONGRESS ASSET MANAGEMENT CO portfolio - Quiver Quantitative
IDEXX Software Defect Blamed For At Least 40 Dog Deaths - Law360
What catalysts could drive IDEXX Laboratories Inc. stock higherTrail vs Road Selection & HOKA model picks for your routine - ulpravda.ru
Is IDEXX Laboratories Inc. (IX1) stock at risk of policy regulationMarket Performance Summary & Real-Time Chart Pattern Alerts - Улправда
Fundamentals Check: How IDEXX Laboratories Inc. stock trades before earningsAnalyst Downgrade & Real-Time Sentiment Analysis - ulpravda.ru
Is IDEXX Laboratories Inc. (IX1) stock undervalued historicallyJuly 2025 Rallies & Expert Approved Trade Ideas - Улправда
Will IDEXX Laboratories Inc. stock deliver consistent dividends2025 Market Trends & Weekly High Conviction Ideas - Улправда
Is IDEXX Laboratories Inc. stock attractive after correction2025 Earnings Surprises & AI Powered Market Entry Strategies - ulpravda.ru
Can IDEXX Laboratories Inc. (IX1) stock deliver double digit returnsQuarterly Risk Review & Capital Efficient Trading Techniques - ulpravda.ru
Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More - Yahoo Finance
Palo Alto, Capital One Financial, IDEXX Laboratories And Others: CNBC's 'Closing Trades' - Bitget
Smart Money: Is IDEXX Laboratories Inc. (IX1) stock at risk of policy regulationWeekly Trade Recap & Accurate Entry and Exit Point Alerts - Улправда
Palo Alto, Capital One Financial, IDEXX Laboratories And More: CNBC's 'Final Trades' - Benzinga
Is the current sentiment towards IDEXX Laboratories Inc positive or negative in the market? - Bitget
Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB - CNBC
Is the Market Bullish or Bearish on IDEXX Laboratories Inc? - Benzinga
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? - Eastern Progress
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
What to expect from IDEXX Laboratories’ next quarterly earnings report - MSN
2026 world cup key players explained: Can IDEXX Laboratories Inc. stock deliver surprise earnings beat2026 world cup usa national team round of 16 playmakers high defensive line odds analysis preview - ulpravda.ru
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN
What to Expect From IDEXX Laboratories’ Next Quarterly Earnings Report? - Barchart.com
What to Expect From IDEXX Laboratories' Next Quarterly Earnings Report? - FinancialContent
Railway Pension Investments Ltd Has $189.45 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
IDEXX Laboratories: How a Quiet Diagnostics Giant Is Rewriting the Future of Animal Health - AD HOC NEWS
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at Wall Street Zen - MarketBeat
Published on: 2026-01-03 12:35:09 - moha.gov.vn
ETF Watch: Is IDEXX Laboratories Inc IX1 stock undervalued historically2025 Historical Comparison & Weekly High Return Stock Forecasts - moha.gov.vn
Here's How Much $1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - Benzinga
Lazard Freres Gestion S.A.S. Sells 12,205 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Ninety One UK Ltd Sells 22,366 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Ninety One SA PTY Ltd Sells 4,317 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):